Global Interventional Cardiology Market is Projected to Reach US$22.2 Billion by 2016; Find New Report

Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016, growing at a CAGR of 9.2% for the analysis period 2012-2018 respectively. North American region accounts for highest percentage approximately 35.8% (2015) of global share while Europe follows next with nearly 28.8% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.6% driving a market value of US$4.7 billion by 2015.

On a global scale, projections for Coronary Stents market share indicate nearly 47.1% by 2015 leaving the rest of the market to the Cardiac Catheters, PTCA/Coronary Guidewires, etc. By technology Optical Coherence Tomography (OCT) is the fastest growing market. PCI Procedures market is expected to reach US$4.8 billion by 2016 across world.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report ‘Interventional Cardiology (Devices& Technology) - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with by devices & technology. Further, the subdivided categories include:

Interventional Cardiology Devices - By Devices &Technology

1.    Devices

A.    Coronary Stents

a.    Drug-Eluting Stents (DES)

b.    Bare Metal Stents (BMS)

c.     Absorbable Stents/Biodegradable Metallic Stent

d.    Anti-Restenosis Devices

                                                  i.    Bioactive Stent

                                                 ii.    Radioactive Stent

                                                iii.    Drug Eluting Balloon (DEB) / Drug Coated Balloon (DCB)

B.    Cardiac Catheters

a.    Electrophysiology (EP) Catheters

b.    PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloons Catheters

c.     Intravascular Ultrasound (IVUS)

d.    PTA (Percutaneous Transluminal Angioplasty) Balloons

e.    Guiding Catheters

f.     Angiography Catheters

g.    Pulmonary Artery Catheters

h.    Inflation Devices & Accessories

C.    PTCA/Coronary Guidewires

D.    Arteriotomy Closure Devices &

E.    Introducer Sheaths& Other (Accessory Devices)

2.    Technology

A.    Fractional Flow Reserve (FFR)

B.    Optical Coherence Tomography (OCT)

The period considered for the interventional cardiology devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 375 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at –  http://mrr.cm/ZyX

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare